Increased respiratory rate after Grapiprant (Galliprant) in dogs
26 reports to the FDA describe increased respiratory rate in dogs given Grapiprant. That is 0.3% of all reports for this medicine, compared with 0.1% across reports for all dog medicines, so it is reported unusually often with this medicine.
26Reports
85%Marked serious
3.8%Recovered
42%Died or euthanised
13 daysTypical onset
Sponsored
How soon it started
How the animals did
Problems reported at the same time
Age of the animals
About this medicine
Grapiprant relieves arthritis pain (a piprant, a newer non-COX NSAID).
Products with this ingredient include Galliprant. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.
NSAIDs can affect the stomach, liver and kidneys. Vets usually recommend blood tests before and during long-term use.
Questions owners ask
- Can Grapiprant cause increased respiratory rate in dogs?
- 26 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
- How soon after a dose was it reported?
- In half of the reports with dates, it started within 13 days of the first dose.
- What should I do?
- Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).
Increased respiratory rate with similar medicines
- Increased respiratory rate after Carprofen (Rimadyl) 79 reports · 0.2% of its reports
- Increased respiratory rate after Deracoxib (Deramaxx) 20 reports · 0.2% of its reports
- Increased respiratory rate after Meloxicam (Metacam) 27 reports · 0.3% of its reports
All reported side effects of Grapiprant in dogs · Medicines most reported with increased respiratory rate